Peptide Decoding
New?New to peptides?Start here →
Decoding

Vilon_Dosage, benefits & legal status

Also known as KE, Lys-Glu

Published July 22, 2026 · Updated August 14, 2026

A tiny bioregulator taken in courses for immunity and aging, with thin evidence.

Immune & agingDi-peptide bioregulatorResearch only
Common vial size10 mg
DoseVaries (course-based)
FrequencyCourses
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledTaken in courses

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Vilon?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is marketed for immune balance and healthy aging. There is very little real human research behind it.

The technical version

Vilon is a 2-amino-acid 'bioregulator' from the Russian Khavinson family.

What it's used for

A tiny two-part bioregulator taken in courses for immune balance and healthy aging.

02

How does Vilon work?

What it does in the body, and where.

Vilon is two amino acids long, lysine and glutamic acid. It is among the shortest compounds on this site.

  1. 01
    The claim is immune regulation
    Used in short courses on the theory that very short peptides influence gene expression in immune tissue.
  2. 02
    There is no citable published range or trial
    Russian-language institute work only, unreplicated.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Immune balance and healthy agingResearch only

The published record

Research index

64

Records indexed for Vilon

20 in humans, 12 of them original studies.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

Vilon vial rendering
Compound field notes

At a glance

Four things to know about Vilon

01

Evidence

Research only

02

Category

Immune support

03

Common vial

10 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Varies (course-based), courses. Taken in coursesCommunity practice

Course dosing is how this one is normally used. Where the course length comes from is the thing to check: for most compounds in this pattern it is convention rather than a tested schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has ever been published for any of the Russian bioregulator peptides, in people or in animals. The research behind them, mostly from one group in St Petersburg, measures effects on tissue, gene activity and lifespan. None of it measures how long the peptide stays in the body.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: Varies (course-based)No range

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

0 / 100 units
What it costs

Vilon starts at $37.00 across 11 vendors, typically $2.70 – $4.00 per mg.

14 listings, last read Sep 5, 2026. Shipping and card fees are not included.

See all 14 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Vilon keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Any prescription medicine you take regularly, without checking for interactions first
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Spreading hives, swelling of the face or throat, or trouble breathing, which can happen with any injection and is a medical emergency
  • Redness, heat, or pus at the injection site, which can signal infection
  • Any severe or unexpected symptom
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Little human evidence.
  • Redness, soreness, or a small bump at the injection site
  • Beyond the above, unknown. There is no reliable human data on what this compound commonly causes

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Vilon approved?

And where the numbers on this page come from.

No. Vilon is not approved for any use, anywhere. It is sold labelled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    August 2026

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

You can compare this against the whole library, or read how to check a seller.


Guides for this compound

Sources

  • Avolio et al., Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line (International Journal of Molecular Sciences 23:3607)(2022)
    One of the few peer-reviewed papers to test Vilon against its siblings in a single experiment, and Vilon is the one that did not perform. Where the other four peptides increased phosphorylation of ERK1/2, the kinase the authors used as their marker of proliferative signalling, Vilon showed what they describe as only a small modulatory capacity. It did contribute to the shared anti-inflammatory effect, reducing TNF and IL-6 release after bacterial lipopolysaccharide, and it activated STAT1. Two limits belong on this alongside the result. Everything here is a human leukemia cell line incubated overnight at 100 ng/mL, with no animal or human data, and Khavinson and two colleagues from his Saint Petersburg institute are co-authors, so this is not the independent replication this family of compounds still lacks.

Last reviewed 14 August 2026

Beyond these, 64 records are indexed. Browse the records